Latest filing published 20 Jul 2023 for GSK plc, €6,884.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
D Conrad: trading record in brief
D Conrad appears in our data through filings on GSK plc shares, published by RNS (LSE). In total, 7 filings cover trades dated from 27 July 2022 to 18 July 2023.
On the market, this insider has only ever bought: 1 purchase, €225k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants.
On 20 July 2023 came the latest disclosure, a share grant for €6,884 in GSK plc. The latest purchase dates back some time: it was published 1,561 days ago, on 1 August 2022. Filings reach the RNS (LSE) feed a median of 3 days after the trade. The regulation allows three business days to notify a trade (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to D Conrad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 445 shares@ £13.3098.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-2
- 0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-14
- 5 shares@ £13.3541.1% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-1
- 324 shares@ £13.226London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543614-4
- 6.988 shares@ £13.5718London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543310-2
- 6 shares@ £13.3383London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4537632-2
- 5,300 shares@ US$43.42New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4460168Canonical exit: 25 Oct 2022 (T+90)
7 of 7 declarations
